Therefore, while the previous study by this group in the EPIC cohort linked high OPG with a slightly reduced risk for ER+ breast cancer, after breast cancer development, higher OPG levels correlate with poorer prognosis in this patient group. Here, TNFRSF11B is linked to breast carcinoma.